John Overdeck’s Xenetic Biosciences XBIO Stock Holding History

John Overdeck’s Portfolio XBIO Stock Details XBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-16,307	Closed	-$334K	–	4962
2021 Q3	$334K	Buy	+16,307	New	+$444K	﹤0.01%	3578

Other funds holding XBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

John Overdeck's XBIO Position: Q4 2021 in Review

John Overdeck sold out of Xenetic Biosciences (XBIO) in Q4 2021, closing a stake of 16,307 shares — an estimated $334K sold.

John Overdeck first reported a position in XBIO in Q3 2021 and held it in 1 quarter. The position peaked at $334K in Q3 2021. 22 funds tracked by Wall St. Rank hold XBIO as of Q4 2021.

John Overdeck reported no remaining Xenetic Biosciences position as of Q4 2021 after selling out during the quarter.
John Overdeck sold 16,307 Xenetic Biosciences shares in Q4 2021, an estimated $334K.
John Overdeck first reported a position in Xenetic Biosciences in Q3 2021 and held it in 1 quarter.
John Overdeck's Xenetic Biosciences position peaked at $334K in Q3 2021.
22 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q4 2021.

Based on Two Sigma Investments's 13F filing for Q4 2021, filed 14 Feb 2022.